Search

AtriCure Inc

Fechado

SetorSaúde

48.4 -1.77

Visão Geral

Variação de preço das ações

24h

Atual

Mín

48.32

Máximo

49.72

Indicadores-chave

By Trading Economics

Rendimento

8.8M

9M

Vendas

12M

154M

P/E

Médio do Setor

213.191

57.371

EPS

0.18

Margem de lucro

5.83

Funcionários

1,350

EBITDA

-3.8M

3.2M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

-0.55% downside

Dividendos

By Acuity

Próximos Ganhos

28 de out. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

516M

2.3B

Abertura anterior

50.17

Fecho anterior

48.4

Sentimento de Notícias

By Acuity

80%

20%

317 / 340 Ranking em Healthcare

AtriCure Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de ago. de 2026, 19:36 UTC

News

AtriCure's price target raised to $55 from $45 by BTIG. Shares are higher, reflecting positive sentiment on the company's growth prospects.

20 de ago. de 2026, 19:46 UTC

AtriCure Inc shares are higher today, maintaining gains since Wednesday's close, despite earlier fluctuations. The stock remains above its 20-day moving average.

19 de ago. de 2026, 20:01 UTC

AtriCure Inc shares are trading higher during Wednesday's session, continuing a strong upward trajectory since Tuesday's close, despite no specific news identified.

18 de ago. de 2026, 19:16 UTC

AtriCure Inc shares are higher today, continuing momentum from Monday's close. Broader market factors include rising U.S. Treasury yields amid inflation concerns.

17 de ago. de 2026, 22:46 UTC

AtriCure Inc is trading higher in after-market hours, with no specific news identified for the move. The stock remains above its 20-day moving average.

12 de ago. de 2026, 20:06 UTC

AtriCure Inc shares are higher today, continuing a nine-session streak of gains. The stock remains above its 20-day moving average.

11 de ago. de 2026, 22:41 UTC

AtriCure Inc shares are higher in after-market trading, continuing a recent trend of strength amid changing monetary policies from central banks.

7 de ago. de 2026, 20:03 UTC

AtriCure Inc's shares are higher during Friday's session, continuing an upward trend since Thursday's close, and remain above their 20-day moving average.

6 de ago. de 2026, 19:12 UTC

AtriCure Inc shares are higher, benefiting from an upward trend in the Health Care Equipment sub-sector. Earlier, the stock peaked before a slight pullback.

5 de ago. de 2026, 19:51 UTC

AtriCure Inc shares are higher today, despite no specific news. Broader market sentiment is cautious following ADP's disappointing employment report.

3 de ago. de 2026, 20:06 UTC

AtriCure Inc. shares are higher during Monday's session, regaining ground after an earlier pullback. Broader market trends support positive investor sentiment.

31 de jul. de 2026, 20:03 UTC

News

AtriCure shares are lower amid significant insider selling, including a $233,280 sale by Chief Scientific Officer Vinayak Doraiswamy and options exercised by Board Member Sven Wehrwein.

30 de jul. de 2026, 18:56 UTC

AtriCure Inc's shares are lower today, impacted by declines in the Health Care Equipment sub-sector. No specific company news was identified for the movement.

29 de jul. de 2026, 20:03 UTC

News

AtriCure Inc shares reached a 52-week high of $43.18 following better-than-expected quarterly earnings, despite a pullback earlier in the session.

28 de jul. de 2026, 19:21 UTC

AtriCure Inc's shares are higher today amid stronger gains in U.S. and European indices, with no specific company news identified for the movement.

27 de jul. de 2026, 20:02 UTC

News

AtriCure Inc shares are higher as the company prepares for two investor conferences and highlights CEO Michael Carrel's leadership appointment.

24 de jul. de 2026, 21:41 UTC

AtriCure Inc. shares traded roughly flat in after-market hours. The stock has performed well recently, positioned near the upper end of its monthly range.

23 de jul. de 2026, 21:51 UTC

News

AtriCure reported strong Q2 results and raised EPS guidance but shares fell in after-market trading, marking the sixth consecutive session of declines.

22 de jul. de 2026, 19:56 UTC

AtriCure Inc shares are trading lower, reaching a session low just before 15:30 ET, despite remaining above the 20-day moving average.

21 de jul. de 2026, 19:16 UTC

AtriCure Inc shares are trading lower today, continuing a trend of declines over the past three sessions, despite gains in the Nasdaq 100 Index.

20 de jul. de 2026, 19:51 UTC

AtriCure Inc continues higher today, maintaining strength since Friday's close, despite a recent pullback earlier in the session.

Comparação entre Pares

Variação de preço

AtriCure Inc Previsão

Preço-alvo

By TipRanks

-0.55% parte inferior

Previsão para 12 meses

Média 48.71 USD  -0.55%

Máximo 55 USD

Mínimo 36 USD

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para AtriCure Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

8 ratings

6

Comprar

2

Manter

0

Vender

Sentimento

By Acuity

317 / 340 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre AtriCure Inc

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
help-icon Live chat